Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 829

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 829
---
, 2023. The Company classifies its marketable debt securities based on their contractual maturity dates. As of December 31, 2023, the Company’s marketable debt securities mature at various dates through November 2024. The amortized cost and fair values of marketable debt securities by contractual maturity were as follows:

| ​                     | ​ | ​ | As of December 31, 2023 |   |        |   |   |   |            |   |        |   | ​ | ​ | As of December 31, 2022 |   |        |   |   |   |            |   |        |   | ​ |
|:----------------------|:--|:--|:------------------------|:--|-------:|:--|:--|:--|:-----------|:--|-------:|:--|:--|:--|:------------------------|:--|-------:|:--|:--|:--|:-----------|:--|-------:|:--|:--|
| Contractual maturity  | ​ | ​ | Amortized Cost          |   |        |   | ​ | ​ | Fair Value |   |        |   | ​ | ​ | Amortized Cost          |   |        |   | ​ | ​ | Fair Value |   |        |   | ​ |
| Less than one year    | ​ | ​ | ​                       | $ | 49,243 | ​ | ​ | ​ | ​          | $ | 48,983 | ​ | ​ | ​ | ​                       | $ | 82,678 | ​ | ​ | ​ | ​          | $ | 81,658 | ​ | ​ |
| One year to two years | ​ | ​ | ​                       | ​ |      — | ​ | ​ | ​ | ​          | ​ |      — | ​ | ​ | ​ | ​                       | ​ | 12,002 | ​ | ​ | ​ | ​          | ​ | 11,350 | ​ | ​ |
| Total                 | ​ | ​ | ​                       | $ | 49,243 | ​ | ​ | ​ | ​          | $ | 48,983 | ​ | ​ | ​ | ​                       | $ | 94,680 | ​ | ​ | ​ | ​          | $ | 93,008 | ​ | ​ |

All available-for-sale marketable securities are classified as marketable securities, current